Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Morphine-Like Synthetic Pain Killer Lacks Side Effects

By LabMedica International staff writers
Posted on 06 Jun 2011
A team of pharmaceutical chemists has successfully synthesized conolidine, a rare natural product that is a potent analgesic as effective as morphine in alleviating inflammatory and acute pain, with few, if any, side effects.

Management of chronic pain is usually based on opioid analgesics despite the fact that they suffer from substantial liabilities that include addiction and tolerance, as well as depression of breathing, nausea, and chronic constipation.

In the current study investigators at the Scripps Research Institute (Jupiter, FL, USA) sought to develop a method for the synthesis of conolidine, a rare C5-nor stemmadenine natural product recently isolated from the stem bark of Tabernaemontana divaricata (a tropical flowering plant used in traditional Chinese, Ayurvedic, and Thai medicine). More...
Details of their research were published in the May 23, 2011, online edition of the journal Nature Chemistry.

"This was a classic problem in chemical synthesis," said Dr. Glenn Micalizio, associate professor in of chemistry at the Scripps Research Institute, "which we were able to solve effectively and efficiently--an achievement that made subsequent assessment of the potential therapeutic properties of this rare natural product possible."

The synthetic conolidine was tested in a mouse model of tonic and persistent pain. Results showed that the new synthetic compound suppressed acute pain and inflammatory-derived pain, two key measures of efficacy. The new compound passed easily through the blood-brain barrier, and was present in the brain and blood at relatively high concentrations up to four hours after injection.

"Pharmacological studies confirmed that while it is not an opiate, it is nearly as potent as morphine," said Dr. Micalizio.

Related Links:

Scripps Research Institute





New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.